In Brief: Pharmaceutical Product Complaints and Recalls
- Pharmaceutical product complaints can reveal quality problems after a drug reaches patients.
- QA teams document complaints, investigate potential causes, and look for related trends.
- Quality complaints and adverse events are different, but one report can involve both.
- Confirmed quality issues affecting distributed products may contribute to a drug product recall.
A tablet looks different from the others in its bottle. A liquid medicine has an unusual odor. A package contains the wrong strength. Once a pharmaceutical product has reached patients, reports like these can become important quality signals.
That is why pharmaceutical product complaints extend far beyond customer service. QA teams need systems for receiving complaints, documenting what happened, assessing whether product quality may be affected, investigating when required, and determining what further action may be necessary.
For students in our pharmaceutical quality assurance training, following a complaint from receipt through investigation, and potentially to recall, shows how quality systems continue to work after a batch leaves the manufacturing site.
What Is A Pharmaceutical Product Complaint?
It is a report concerning a drug product that may raise questions about its quality, identity, strength, purity, packaging, labeling, performance, or other characteristics.
FDA requires written procedures for handling written and oral drug-product complaints. Complaints involving a possible failure to meet specifications require quality-unit review and a determination of whether an investigation is necessary.
Effective pharmaceutical complaint handling therefore depends on accurate documentation from the beginning.
What Types of Pharmaceutical Product Complaints Do Companies Receive?
What types of product complaints do pharmaceutical companies receive? They can involve contamination, defective components, packaging problems, product mix-ups, questionable stability, labeling concerns, or other suspected quality defects.
FDA identifies these among the product-quality problems that can occur during manufacturing, shipping, or storage.
A complaint might concern a broken tablet, leaking container, unexpected appearance, incorrect label, damaged seal, or unusual product condition. The report becomes information that QA can evaluate rather than an automatic conclusion that manufacturing failed.
Understanding pharmaceutical manufacturing methods can help future QA professionals understand where potential quality issues may originate.
How QA Teams Investigate Pharmaceutical Product Complaints
During a quality complaint investigation, the team documents the report, assesses the potential quality issue, determines whether an investigation is required, and reviews relevant evidence to identify what happened and whether other product may be affected.
Depending on the complaint, a product complaint investigation in pharma may consider:
- Product and lot information
- Manufacturing and packaging records
- Laboratory or release data
- Retain samples, when appropriate
- Distribution information
- Similar complaints or trends
- Potential root causes
- Corrective and preventive actions when warranted
FDA has cited firms for inadequate complaint investigations, failure to identify trends, and failure to implement effective corrective and preventive actions.
These responsibilities connect directly with the principles students encounter when studying current Good Manufacturing Practices and quality systems.
Adverse Events And Product Quality Complaints Are Different
An adverse event concerns an undesirable experience associated with a medical product, while a product quality complaint concerns a suspected problem with the product itself.
The two can overlap.
For example, a patient might report both a leaking medication container and an adverse health experience. FDA’s MedWatch program accepts reports of serious adverse events as well as product-quality problems such as contamination, defective components, poor packaging, and product mix-ups.
Complaint procedures therefore need a way to identify reports that may also require adverse-event evaluation and reporting. FDA CGMP requirements also require complaint procedures to address whether a complaint may represent a reportable adverse drug experience.
When Can A Product Complaint Lead To A Drug Recall?
A complaint can contribute to a recall decision when an investigation identifies a problem affecting distributed product and removal or correction is needed. One complaint may reveal a wider issue. Repeated reports can also expose a pattern that was not obvious when individual complaints were viewed separately.
For most human drugs in the United States, recalls are voluntary and may be initiated by a firm or requested by the FDA. FDA classifies recalls as Class I, II, or III according to the relative health hazard presented.
The pharmaceutical recall process can involve identifying affected lots, determining distribution, communicating with customers, retrieving or correcting affected product, and checking recall effectiveness. FDA monitors recalls and publishes them through its Enforcement Report.
For future QA professionals, the larger lesson is straightforward: quality oversight does not end when manufacturing does. Complaint records can reveal what happens to products in real-world use, and sometimes provide the evidence needed to protect patients from a broader quality problem.
Are you looking for comprehensive pharmaceutical quality assurance training?
Contact the NeuAge Institute for more information.
Key Takeaways
- Pharmaceutical product complaints can provide important post-distribution quality information.
- FDA CGMP requirements address written procedures, quality-unit review, complaint records, and investigations.
- Complaint investigations can connect patient reports with manufacturing, laboratory, packaging, and distribution records.
- Product quality complaints and adverse events are different, but one report can involve both.
- Complaint trends may reveal broader quality-system problems.
- A confirmed problem affecting distributed product may contribute to a drug product recall.
FAQ
What is a pharmaceutical product complaint?
It is a report that raises a concern about a drug product’s quality or other product characteristics and may require review or investigation under the manufacturer’s complaint-handling procedures.
What types of product complaints do pharmaceutical companies receive?
Examples include contamination concerns, damaged or defective components, packaging problems, product mix-ups, questionable stability, labeling issues, or unexpected product appearance.
How does a QA team investigate a pharmaceutical complaint?
QA can review the complaint details alongside relevant batch, manufacturing, packaging, laboratory, distribution, and complaint-history information to determine what happened, whether other product may be affected, and whether corrective action is necessary.
What is the difference between an adverse event and a product quality complaint?
An adverse event concerns an undesirable experience associated with a medical product. A product quality complaint concerns a suspected problem with the product. A single report can involve both.
When can a product complaint lead to a drug recall?
A complaint can contribute to a recall when investigation identifies a problem with distributed product that warrants removal or correction. The response depends on the nature, scope, and risk of the identified problem.
